Literature DB >> 8415841

Effect of D-cycloserine on rapid tolerance to ethanol.

J M Khanna1, H Kalant, G Shah, A Chau.   

Abstract

We recently reported that the noncompetitive NMDA antagonists, (+)MK-801 and ketamine, block the development of rapid tolerance to ethanol. In the present article, we show that D-cycloserine (CS), an agonist at the glycine site of the NMDA receptor that enhances learning and memory, also enhances the development of rapid tolerance to ethanol. Rats were pretreated on day 1 with saline or CS, followed 30 min later by ethanol (2.3 g/kg, IP) or saline. At the end of motor impairment testing on the tilt-plane apparatus, a second injection of CS (3 mg/kg, IP, each time) or saline was given, followed 30 min later by ethanol or saline. Ethanol pretreatment alone (at this dose) did not result in rapid tolerance to ethanol on day 2. However, the group pretreated with CS and ethanol on day 1 showed significant tolerance on day 2 compared to other groups. Pretreatment with CS on day 1 did not affect the motor impairment response to the first exposure to ethanol whether this was on day 1 or day 2. In another experiment, administration of (+)MK-801 (0.25 mg/kg, IP) prior to CS abolished the rapid tolerance enhancement by CS. These findings are further evidence that the NMDA system, which requires activation by the glycine receptor, plays a major role in the development of at least some forms of ethanol tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415841     DOI: 10.1016/0091-3057(93)90152-j

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

2.  Probing the modulation of acute ethanol intoxication by pharmacological manipulation of the NMDAR glycine co-agonist site.

Authors:  Lauren Debrouse; Benita Hurd; Carly Kiselycznyk; Aaron Plitt; Alyssa Todaro; Masayoshi Mishina; Seth G N Grant; Marguerite Camp; Ozge Gunduz-Cinar; Andrew Holmes
Journal:  Alcohol Clin Exp Res       Date:  2012-08-30       Impact factor: 3.455

3.  Long-lasting ibogaine protection against NMDA-induced convulsions in mice.

Authors:  M B Leal; D O de Souza; E Elisabetsky
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

4.  The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex.

Authors:  P Popik; R T Layer; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

Review 5.  Tolerance to alcohol: A critical yet understudied factor in alcohol addiction.

Authors:  Sophie K Elvig; M Adrienne McGinn; Caroline Smith; Michael A Arends; George F Koob; Leandro F Vendruscolo
Journal:  Pharmacol Biochem Behav       Date:  2021-02-23       Impact factor: 3.533

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.